U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for Treatment of Adults with Psoriatic Arthritis
On Mar. 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved…
-
-
huge study highlights new health risks of Obesity drugs
On Jan. 20, 2025, an analysis of data from nearly 2 million people has revealed new insights into…
-
Medical imaging breakthrough could transform cancer and arthritis diagnosis
On Sept. 30, 2024, a University College London research team announced technology that can deliver photoacoustic tomography (PAT)…
-
Stanford researchers discovered hereditary arthritis gene
On Jul. 11, 2000, Stanford researchers announced they had identified a substance commonly added to toothpaste to prevent…
-
Dr. Morris Reichlin became head the OMRF Arthritis and Immunology Program
In 1981, Dr. Morris Reichlin joined the Oklahoma Medical Research Foundation (OMRF) to head the Arthritis and Immunology…
-
German chemist Felix Hoffmann synthesized aspirin and heroin
On Aug. 10, 1897, German chemist Felix Hoffmann searching for something to relieve his father’s arthritis synthesized acetylsalicylic…
